Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

364

HTML

2024

Figures (1-1)

209

Tables (1-5)

149

Sum=2746

Dec 28, 2007 (publication date) through Oct 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 28, 2007; 13(48): 6593-6597
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593

Table 5 Complications observed in 50 patients 2 wk after treatment n (%)

Complications	Group A	Group B	P-value
Abdominal pain	20 (76.9)	18 (75.0)	0.874¹
Fever	22 (84.6)	20 (83.3)	0.903¹
Mild nausea and vomiting	5 (19.2)	6 (25.0)	0.623¹
Large amount of pleural effusion or ascites	1 (3.9)	6 (29.2)	0.016¹
Bacterial peritonitis	1 (3.9)	6 (25.0)	0.033¹
Variceal bleeding	1 (3.9)	7 (29.2)	0.016¹

¹Data are determined with the χ² test.

Citation: Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007; 13(48): 6593-6597
URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6593.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6593